Bladder carcinoma among live-donor renal transplant recipients: A single-centre experience and a review of the literature

BJU International

Volumn 101, Issue 1, 2008, Pages 30-35

  Kamal, Mohamed M ^a   Soliman, Shady M ^a   Shokeir, Ahmed A ^a   Abol Enein, Hassan ^a   Ghoneim, Mohamed A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Bladder cancer; Immunosuppression; Renal transplantation

Indexed keywords

AZATHIOPRINE; BCG VACCINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADULT; ARTICLE; BLADDER CARCINOMA; BLADDER RECONSTRUCTION; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CONTROLLED STUDY; CYSTECTOMY; DISEASE SEVERITY; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMATURIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MUSCLE METASTASIS; PRIORITY JOURNAL; TRANSURETHRAL RESECTION; TREATMENT OUTCOME;

ADULT; COHORT STUDIES; CYSTECTOMY; EARLY DIAGNOSIS; FEMALE; HEMATURIA; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; URINARY DIVERSION;

EID: 36849063837     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07210.x     Document Type: Article

References (33)

1. Penn I. Post-transplant malignancies. Transplant Proc 1999 31 : 1260 2
2. Ghoneim MA, Kock NG, Lycke G, Shehab El-Din AB. An appliance-free, sphincter-controlled bladder substitute: the urethral Kock pouch. J Urol 1987 138 : 1150 4
3. Abol-Enein H, Ghoneim MA. A novel ureteroileal reimplantation technique: the serous lined extramural tunnel. A preliminary report. J Urol 1994 151 : 1193 7
4. London NJ, Farmery SM, Will EJ, Davison AM, Lodge JPA. Risk of neoplasia in renal transplant patients. Lancet 1995 346 : 403 6
5. Behrend M, Kolditz M, Kliem V et al. Malignancies in patients under long-term immunosuppression after kidney transplantation. Transplant Proc 1997 29 : 834 5
6. Hiesse C, Rieu P, Kriaa F et al. Malignancy after renal transplantation. Analysis of incidence and risk factors in 1700 patients followed during a 25-year period. Transplant Proc 1997 29 : 831 3
7. Marcen R, Pascual J, Tato AM et al. Influence of immunosuppression on the prevalence of cancer after kidney transplantation. Transplant Proc 2003 35 : 1714 6
8. Master VA, Meng MV, Grossfeld GD, Koppie TM, Hirose R, Carroll PR. Treatment and outcome of invasive bladder cancer in patients after renal transplantation. J Urol 2004 171 : 1085 8
9. Buzzeo BD, Heisey DM, Messing EM. Bladder cancer in renal transplant recipients. Urology 1997 50 : 525 8
10. Kao Y-L, Ou Y-C, Yang C-R, Ho H-C, Su C-K, Shu K-H. Transitional cell carcinoma in renal transplant recipients. World J Surg 2003 27 : 912 6
11. Liao C-H, Chueh S-CJ, Lai M-K, Chen J. Transitional cell carcinoma in renal transplant recipients. Transplant Proc 2004 36 : 2152 3
12. El-Bolkainy MN, Mokhtar NM, Ghoneim MA, Hussien MH. The impact of schistosomiasis on the pathology of bladder carcinoma. Cancer 1981 48 : 2643 8
13. Lemmers MJ, Barry JM. De novo carcinoma of the lower urinary tract in renal allograft recipients. J Urol 1990 144 : 1233 5
14. Birkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet 2000 355 : 1886 7
15. Lang H, de Petriconi R, Wenderoth U, Volkmer BG, Hautmann RE, Gschwend JE. Orthotopic ileal neobladder reconstruction in patients with bladder cancer following renal transplantation. J Urol 2005 173 : 881 4
16. Cherikh WS, Kauffman HM, McBride MA, Maghirang J, Swinnen LJ, Hanto DW. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival and patient survival after primary kidney transplantation. Transplantation 2003 76 : 1289 93
17. Diller R, Gruber A, Wolters H, Senninger N, Spiegel H-U. Therapy and prognosis of tumours of the genitourinary tract after kidney transplantation. Transplant Proc 2005 37 : 2089 92
18. Schmidt R, Stippel D, Krings F, Pollok M. Malignancies of the genitourinary system following renal transplantation. Br J Urol 1995 75 : 572 7
19. Lam KY, Chan KW, Low K. Bladder carcinoma in a renal transplant patient. Br J Urol 1993 72 : 511 3
20. Moinuddin SM, Upton DW. Urothelial carcinoma after cyclophosphamide therapy. J Urol 1983 129 : 143 4
21. Tuttle TM, Williams GM, Marshall FF. Evidence for cyclophosphamide- induced transitional cell carcinoma in a renal transplant patient. J Urol 1988 140 : 1009 11
22. Previte SR, Murata GT, Olsson CA, Schmitt GW, Nabseth DC, Cho SI. Hematuria in renal transplant recipients. Ann Surg 1978 187 : 219 22
23. Palou J, Angerri O, Segarra J et al. Intravesical Bacillus Calmette-Guerin for the treatment of superficial bladder cancer in renal transplant patients. Transplantation 2003 76 : 1514 6
24. Colombo T, Zigeuner R, Zitta S, Petritsch PH, Hubmer G. Orthotopic neobladder in a women after kidney transplantation. J Urol 1997 158 : 2236 337
25. Perabo FG, Schultze-Seemann W. Continent orthotopic ileal neobladder after kidney transplantation in a female patient with multifocal transitional cell carcinoma. J Urol 1998 159 : 1635 6
26. Giessing M, Turk I, Schoenberger B, Loening SA. Orthotopic neobladder after kidney transplantation in a male patient with recurring urothelial carcinoma and renal cancer. J Urol 2001 166 : 1383
27. Kristjansson A, Engellau L, Willner J, Masson W. Reflux, stricture and glomerular filtration rate after two antireflux techniques in continent urinary reconstruction using the right colon. Scand J Urol Nephrol 1997 31 : 425 9
28. Hautmann RE, Egghart G, Frohneberg D, Miller K. The ileal neobladder. J Urol 1988 139 : 39 42
29. Burkhard FC, Studer UE. Orthotopic bladder substitution. Curr Opin Urol 2000 10 : 343 9
30. Ogino Y, Kobayashi E, Kita J, Fujimura A, Kogure H. The site of absorption of cyclosporin A in the small intestine of the rat: a preliminary report. Transplant Proc 1999 31 : 2659 60
31. Drewe J, Beglinger C, Kissel T. The absorption site of cyclosporin in the human gastrointestinal tract. Br J Clin Pharmacol 1992 33 : 39 43
32. Zmonarski SC, Boratynska M, Rabzynski J, Kazimierczak K, Klinger M. Regression of Kaposi's sarcoma in renal graft recipients after conversion to sirolimus treatment. Transplant Proc 2005 37 : 964 6
33. Stallone G, Schena A, Infante B et al. Sirolimus for Kaposi's sarcoma in renal transplant recipients. N Engl J Med 2005 352 : 1317 23